Biotech

All Articles

Roche is holding out hopes that its injectable excessive weight prospect could ultimately illustrate 25% effective weight loss in late-stage test

.Roche is actually storing out chances that its injectable excessive weight possibility might at som...

Novo Nordisk barrages 'amazing' weight-loss result for dual-acting dental drug in early trial

.Novo Nordisk has raised the cover on a phase 1 test of its dental amylin and also GLP-1 receptor co...

AbbVie sues BeiGene over blood stream cancer cells medicine proprietary knowledge

.Merely a handful of quick weeks after succeeding an FDA Fast lane tag for its own investigational B...

Lilly provides one-two punch with 2nd tranche of beneficial data on once a week insulin applicant

.Shortly after a beneficial information decline for Eli Lilly's efsitora alfa, the Indianapolis-base...

BridgeBio reduces gene therapy finances as scientific information disappoint

.BridgeBio Pharma is actually lowering its own genetics treatment finances as well as drawing back c...

GSK submits HSV vaccine hopes after phase 2 neglect, signing over race to Moderna, BioNTech

.GSK's attempt to establish the initial vaccine for genital herpes simplex infection (HSV) has actua...

GSK's long-acting asthma medicine halved assaults in phase 3

.GSK's long-acting breathing problem treatment has actually been revealed to cut in half the number ...

AstraZeneca, Daiichi unpack Dato-DXd's total survival stop working

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually stopped ...

Roivant reveals new 'vant' to accelerate Bayer hypertension med

.Matt Gline is back with a new 'vant' provider, after the Roivant Sciences chief executive officer s...

Viridian eye disease stage 3 hits, progressing push to competing Amgen

.Viridian Therapeutics' stage 3 thyroid eye ailment (TED) scientific trial has hit its own primary a...